Tobacco Master Settlement Agreement

Tobacco Master Settlement Agreement
Name	Tobacco Master Settlement Agreement
Date signed	November 23, 1998
Parties	Major United States tobacco manufacturers and attorneys general of 46 states, five U.S. territories, and the District of Columbia
Jurisdiction	United States
Outcome	Long-term payments, advertising restrictions, creation of the American Legacy Foundation, release of past claims

Tobacco Master Settlement Agreement The Tobacco Master Settlement Agreement was a landmark 1998 accord between major United States tobacco manufacturers and state attorneys general resolving claims related to health care costs and marketing practices. It produced large-scale financial commitments, detailed restrictions on advertising and promotion, and significant institutional outcomes that affected public health policy, litigation strategy, and corporate conduct across multiple jurisdictions. The agreement reshaped interactions among state attorneys general, manufacturers such as Philip Morris Companies Inc., R.J. Reynolds Tobacco Company, and Brown & Williamson, and spawned debates involving institutions like the United States Congress and the Supreme Court of the United States.

Background

By the mid-1990s a series of lawsuits brought by state attorneys general and private plaintiffs targeted manufacturers including Philip Morris Companies Inc., R.J. Reynolds Tobacco Company, Brown & Williamson Tobacco Corporation, Lorillard Tobacco Company, and Liggett Group. Precedent-setting cases such as those in Florida, Missouri, and Minnesota prompted coordinated action by the attorneys general of states including New York (state), California, Texas, and Massachusetts (state). The litigation drew on investigative work from journalists at outlets like the New York Times, research from scholars at institutions such as Harvard University, and depositions previously used in litigation against corporations like Dow Chemical Company and General Electric Company. Political figures including Jesse Ventura and George W. Bush weighed in as state executives confronted budgetary pressures tied to rising healthcare costs in state programs such as Medicaid and state-run institutions like Massachusetts General Hospital. The public health community, represented by organizations like the American Lung Association, American Cancer Society, and Centers for Disease Control and Prevention, pushed for remedies that addressed youth smoking and industry marketing.

Terms of the Agreement

The accord required participating manufacturers including Philip Morris USA, R.J. Reynolds Tobacco Company, Brown & Williamson, Lorillard Tobacco Company, and Liggett Group to make annual payments to plaintiff states and territories in perpetuity, subject to volume adjustments. It barred industry practices such as certain forms of outdoor advertising, brand sponsorships tied to entities like NASCAR and National Collegiate Athletic Association, and use of cartoons akin to Joe Camel or sponsorship of events associated with celebrities like Mick Jagger or Madonna (entertainer). The settlement mandated creation of the American Legacy Foundation and funded cessation programs involving actors such as Michael Bloomberg and medical centers like Johns Hopkins Hospital. It included releases of past claims and covenants not to sue, affecting litigation involving private plaintiffs represented by firms such as Kirkland & Ellis and Covington & Burling.

Financial Distributions and Escrow

Payments under the agreement were allocated to states including New York (state), Florida, California, Pennsylvania, and territories like Puerto Rico and Guam (U.S. territory). The schedule tied disbursements to cigarette shipment volumes and incorporated adjustments used in escrow statutes in states such as Missouri and Mississippi. Funds flowed into state budgets overseen by officials such as state treasurers in jurisdictions like Illinois and Ohio, and were subject to appropriation by legislatures including the California State Legislature and Texas Legislature. Independent escrow and indemnity mechanisms were similar to financial structures used by corporations including American Tobacco Company and institutions such as Bank of America. The settlement influenced municipal finance conversations in cities like Chicago and New York City over use of settlement monies for healthcare, education, and tobacco-control programs.

Legal and Regulatory Impacts

Regulatory frameworks at the federal level, including actions by the Food and Drug Administration, and statutory changes considered by the United States Congress were shaped by the settlement. Litigation strategies by public interest entities such as Public Citizen and law firms like Hogan & Hartson evolved in response to the releases and consent provisions. The accord affected state regulatory schemes involving attorneys general offices in Texas, Massachusetts (state), and Florida and contributed to later federal statutes including provisions debated during hearings chaired by members of the United States Senate Judiciary Committee and the House Committee on Energy and Commerce. Judicial scrutiny in venues like the United States Court of Appeals for the District of Columbia Circuit and the Supreme Court of the United States influenced interpretations of preemption and commerce clauses cited by parties including Altria Group, Inc..

Litigation and Enforcement

Enforcement involved state attorneys general such as those from New York (state), Missouri, Texas, and California (state) monitoring compliance, with disputes brought in state courts and arbitration panels administered under rules like those of the American Arbitration Association. Subsequent litigation included cases brought by non-settling entities including U.S. Smokeless Tobacco Company and challenges by plaintiffs represented by firms such as Lieff Cabraser. Federal enforcers including the Department of Justice (United States) addressed allegations of fraud and racketeering linked to internal documents revealed in litigation, earlier exploited in suits against corporations like Enron Corporation and WorldCom. Compliance audits and subpoenas involved investigative bodies like the Federal Trade Commission and state consumer protection offices such as those in Ohio.

Criticisms and Controversies

Critics including public health scholars at Johns Hopkins Bloomberg School of Public Health and policy analysts at The Brookings Institution argued that states misallocated funds to general expenditures rather than tobacco control. Observers from advocacy groups such as Campaign for Tobacco-Free Kids and journalists at The Washington Post highlighted disputes over projected payment shortfalls tied to consumption declines and strategies by companies like Philip Morris USA to mitigate obligations via international subsidiaries similar to tactics debated by British American Tobacco. Legal scholars at Yale Law School and Stanford Law School criticized releases for limiting future remedies pursued by plaintiffs, and cases involving municipal plaintiffs such as New York City raised questions about fairness and transparency. Controversies also emerged around industry compliance with advertising restrictions affecting sponsorships involving entities like Major League Baseball and media content regulated by networks such as Fox Broadcasting Company.

Legacy and Subsequent Developments

The settlement catalyzed creation of organizations such as the American Legacy Foundation and influenced global tobacco control efforts including the World Health Organization's Framework Convention on Tobacco Control. It reshaped corporate behavior at firms like Philip Morris International and Imperial Tobacco Group and informed state-level measures including smoke-free laws in jurisdictions such as California (state) and New York City. Later litigation, legislative initiatives by bodies like the United States Congress, and regulatory actions by the Food and Drug Administration continued to evolve, prompted by developments involving e-cigarette companies such as Juul Labs and public health campaigns run by institutions like Centers for Disease Control and Prevention. The agreement remains a pivotal episode studied by scholars at Harvard Kennedy School, Yale School of Public Health, and policy centers such as The Heritage Foundation for lessons on multi-state litigation, corporate accountability, and public health financing.

Category:Tobacco control